Projekt

One of the key actions to limit the socio-economic and health impacts of COVID-19 is widespread testing followed by rapid track and trace strategies. However, traditional testing often incurs in delays of several days and relies on expensive equipment. Point of care diagnostic tests overcome this limitation, but for African countries, bottlenecks in the global supply chain of reagents are still a challenge. The project team has developed an open source SARSCoV-2 point of care test that can be locally manufactured in African countries. The aim of this project is to establish its use as a diagnostic tool in two African countries, in view of its future widespread use across the continent.

• Prof. Dr. Joachim Wittbrodt

  Universität Heidelberg
  Centre for Organismal Studies
  Heidelberg
  

• Dr. Thomas Oliver Auer

  Université de Lausanne
  Center for Integrative Genomcis
  Lausanne
  Schweiz
  

• Dr. Lucia Prieto Godino

  The Francis Crick Institute
  London
  Grossbritannien